METHODS FOR THERAPEUTIC RENAL NEUROMODULATION

Patent №

US 9,439,726

Granted

2016-09-13

Filed 2016

Owner

ARDIAN, INC.

+2 more

Lab

AI components

1

hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

15069830

Methods and apparatus are provided for treating hypertension, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.

AI hardwareA61B 18/1492A61F 7/12A61M 5/14276A61N 1/05A61N 1/327A61N 1/36017A61N 1/36117A61N 1/36121+17 more

AI classification

AI hardware0.66
Machine learning0.32
Evolutionary computation0.00
Natural language0.00
Speech0.00
Knowledge representation0.00
Vision0.00
Planning0.00

Ownership

ARDIAN, INC.

assignment · 389740705

MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.

assignment · 389760249

MEDTRONIC ARDIAN LLC

namechg · 391110924

Assignors

DEMARAIS, DENISE, GIFFORD, HANSON, III, DEEM, MARK, SUTTON, DOUGLAS, LEVIN, HOWARD R., GELFAND, MARK

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC